Genetic influence of plasma homocysteine on Alzheimer's disease

被引：6
|
作者：
Lehmann, Donald John [1 ]
Cortina-Borja, Mario [2 ]
机构：
[1] Univ Oxford, Dept Pharmacol, OPTIMA, Mansfield Rd, Oxford OX1 3QT, England
[2] Great Ormond St UCL Inst Child Hlth, Populat Policy & Practice Programme, London, England
来源：
NEUROBIOLOGY OF AGING | 2019年 / 76卷
关键词：
MENDELIAN RANDOMIZATION;
D O I：
10.1016/j.neurobiolaging.2018.08.028
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：217 / 218
页数：2
相关论文
共 50 条
  • [31] Risk of Alzheimer's disease and genetically predicted levels of 1400 plasma metabolites: a Mendelian randomization study
    Cao, Di
    Zhang, Yini
    Zhang, Shaobo
    Li, Jun
    Yang, Qiguang
    Wang, Ping
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [32] Genetic evidence that the causal association of educational attainment with reduced risk of Alzheimer's disease is driven by intelligence
    Thorp, Jackson G.
    Mitchell, Brittany L.
    Gerring, Zachary F.
    Ong, Jue-Sheng
    Gharahkhani, Puya
    Derks, Eske M.
    Lupton, Michelle K.
    NEUROBIOLOGY OF AGING, 2022, 119 : 127 - 135
  • [33] Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease
    Luo, Jiao
    Thomassen, Jesper Qvist
    Bellenguez, Celine
    Grenier-Boley, Benjamin
    de Rojas, Itziar
    Castillo, Atahualpa
    Parveen, Kayenat
    Kuecuekali, Fahri
    Nicolas, Aude
    Peters, Oliver
    Schneider, Anja
    Dichgans, Martin
    Rujescu, Dan
    Scherbaum, Norbert
    Juergen, Deckert
    Riedel-Heller, Steffi
    Hausner, Lucrezia
    Porcel, Laura Molina
    Duezel, Emrah
    Grimmer, Timo
    Wiltfang, Jens
    Heilmann-Heimbach, Stefanie
    Moebus, Susanne
    Tegos, Thomas
    Scarmeas, Nikolaos
    Clarimon, Jordi
    Moreno, Fermin
    Perez-Tur, Jordi
    Bullido, Maria J.
    Pastor, Pau
    Sanchez-Valle, Raquel
    Alvarez, Victoria
    Boada, Merce
    Garcia-Gonzalez, Pablo
    Puerta, Raquel
    Mir, Pablo
    Real, Luis M.
    Pinol-Ripoll, Gerard
    Garcia-Alberca, Jose Maria
    Royo, Jose Luis
    Rodriguez-Rodriguez, Eloy
    Soininen, Hilkka
    Kuulasmaa, Teemu
    de Mendonca, Alexandre
    Mehrabian, Shima
    Hort, Jakub
    Vyhnalek, Martin
    van der Lee, Sven
    Graff, Caroline
    Papenberg, Goran
    JAMA NETWORK OPEN, 2023, 6 (05)
  • [34] The impact of plasma vitamin C levels on the risk of cardiovascular diseases and Alzheimer's disease: A Mendelian randomization study
    Chen, Lu
    Sun, Xingang
    Wang, Zhen
    Lu, Yunlong
    Chen, Miao
    He, Yuxian
    Xu, Hongfei
    Zheng, Liangrong
    CLINICAL NUTRITION, 2021, 40 (10) : 5327 - 5334
  • [35] Genetic Evidence Supporting the Causal Role of Homocysteine in Chronic Kidney Disease: A Mendelian Randomization Study
    Xiong, Yang
    Zhang, Yangchang
    Zhang, Fuxun
    Wu, Changjing
    Luo, Peiyi
    Qin, Feng
    Yuan, Jiuhong
    FRONTIERS IN NUTRITION, 2022, 9
  • [36] Shared molecular genetic factors influence subcortical brain morphometry and Parkinson's disease risk
    Garcia-Marin, Luis M.
    Reyes-Perez, Paula
    Diaz-Torres, Santiago
    Medina-Rivera, Alejandra
    Martin, Nicholas G.
    Mitchell, Brittany L.
    Renteria, Miguel E.
    NPJ PARKINSONS DISEASE, 2023, 9 (01)
  • [37] Evaluating the Causal Effect of Type 2 Diabetes on Alzheimer's Disease Using Large-Scale Genetic Data
    Liu, D.
    Baranova, A.
    Zhang, Fuquan
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2024, 11 (05): : 1280 - 1282
  • [38] No genetic causal association between Alzheimer's disease and osteoporosis: A bidirectional two-sample Mendelian randomization study
    Hu, Hongxin
    Mei, Jian
    Cai, Yuanqing
    Ding, Haiqi
    Niu, Susheng
    Zhang, Wenming
    Fang, Xinyu
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [39] Genetic prediction of blood metabolites mediating the relationship between gut microbiota and Alzheimer's disease: a Mendelian randomization study
    Chen, Guanglei
    Jin, Yaxian
    Chu, Cancan
    Zheng, Yuhao
    Chen, Yunzhi
    Zhu, Xing
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [40] Genetic Evidence Supporting Fibroblast Growth Factor 21 Signalling as a Pharmacological Target for Cardiometabolic Outcomes and Alzheimer's Disease
    Larsson, Susanna C.
    Gill, Dipender
    NUTRIENTS, 2021, 13 (05)
12345